A history of depression in women is associated with an altered GABAergic neuroactive steroid profile

Psychoneuroendocrinology

Volumn 37, Issue 4, 2012, Pages 543-553

  Girdler, Susan S ^a   Lindgren, Monica ^a   Porcu, Patrizia ^a   Rubinow, David R ^a   Johnson, Jacqueline L ^a   Morrow, A Leslie ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

Depression; GABA; Histories of depression; Neurosteroids

Indexed keywords

ANDROSTENEDIONE; HYDROCORTISONE; NEUROSTEROID; PRASTERONE; PREGNENOLONE; PROGESTERONE;

ADRENAL SUPPRESSION; ADULT; ARTICLE; BECK DEPRESSION INVENTORY; CLINICAL ARTICLE; CONTROLLED STUDY; DEPRESSION; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DISEASE ASSOCIATION; FEMALE; GABAERGIC TRANSMISSION; HUMAN; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; MEDICAL HISTORY; MENTAL STRESS; NEUROCHEMISTRY; NEUROMODULATION; NEUROPATHOLOGY; PRIORITY JOURNAL; PROGESTERONE BLOOD LEVEL; PROGESTERONE METABOLISM; SCORING SYSTEM; STEROID BLOOD LEVEL;

ADULT; CASE-CONTROL STUDIES; DEHYDROEPIANDROSTERONE; DEPRESSION; DOUBLE-BLIND METHOD; FEMALE; HUMANS; HYDROCORTISONE; NEUROTRANSMITTER AGENTS; PREGNENOLONE; PROGESTERONE;

EID: 84857191635     PISSN: 03064530     EISSN: 18733360     Source Type: Journal    
DOI: 10.1016/j.psyneuen.2011.08.004     Document Type: Article

References (58)

1. Ahrens T., Deuschle M., Krumm B., van der Pompe G., den Boer J.A., Lederbogen F. Pituitary-adrenal and sympathetic nervous system responses to stress in women remitted from recurrent major depression. Psychosom. Med. 2008, 70(4):461-467.
2. Andreen L., Bixo M., Nyberg S., Sundstrom-Poromaa I., Backstrom T. Progesterone effects during sequential hormone replacement therapy. Eur. J. Endocrinol. 2003, 148(5):571-577.
3. Andreen L., Nyberg S., Turkmen S., van Wingen G., Fernandez G., Backstrom T. Sex steroid induced negative mood may be explained by the paradoxical effect mediated by GABAA modulators. Psychoneuroendocrinology 2009, 34(8):1121-1132.
4. Barbaccia M.L., Roscetti G., Trabucchi M., Purdy R.H., Mostallino M.C., Concas A., et al. The effects of inhibitors of GABAergic transmission and stress on brain and plasma allopregnanolone concentrations. Br. J. Pharmacol. 1997, 120(8):1582-1588.
5. Beauchamp M.H., Ormerod B.K., Jhamandas K., Boegman R.J., Beninger R.J. Neurosteroids and reward: allopregnanolone produces a conditioned place aversion in rats. Pharmacol. Biochem. Behav. 2000, 67(1):29-35.
6. Beck A.T., Ward C.H., Mendelson M., Mock J., Erbaugh J. An inventory for measuring depression. Arch. Gen. Psychiatry 1961, 4:561-571.
7. Biggio G., Purdy R.H. Neurosteroids and Brain Function International Review of Neurobiology 2001, Vol. 46. Academic Press, New York.
8. Bjorn I., Bixo M., Nojd K.S., Collberg P., Nyberg S., Sundstrom-Poromaa I., et al. The impact of different doses of medroxyprogesterone acetate on mood symptoms in sequential hormonal therapy. Gynecol. Endocrinol. 2002, 16(1):1-8.
9. Blanchard D.C., Sakai R.R., McEwen B., Weiss S.M., Blanchard R.J. Subordination stress: behavioral, brain, and neuroendocrine correlates. Behav. Brain Res. 1993, 58(1-2):113-121.
10. De Geyter C., De Geyter M., Huber P.R., Nieschlag E., Holzgreve W. Progesterone serum levels during the follicular phase of the menstrual cycle originate from the crosstalk between the ovaries and the adrenal cortex. Hum. Reprod. 2002, 17(4):933-939.
11. Deuschle M., Hamann B., Meichel C., Krumm B., Lederbogen F., Kniest A., et al. Antidepressive treatment with amitriptyline and paroxetine: effects on saliva cortisol concentrations. J. Clin. Psychopharmacol. 2003, 23(2):201-205.
12. Dong E., Matsumoto K., Uzunova V., Sugaya I., Takahata H., Nomura H., et al. Brain 5alpha-dihydroprogesterone and allopregnanolone synthesis in a mouse model of protracted social isolation. Proc. Natl. Acad. Sci. U. S. A. 2001, 98(5):2849-2854.
13. Eser D., Romeo E., Baghai T.C., di Michele F., Schule C., Pasini A., et al. Neuroactive steroids as modulators of depression and anxiety. Neuroscience 2006, 138(3):1041-1048.
14. Freeman E.W., Weinstock L., Rickels K., Sondheimer S.J., Coutifaris C. A placebo-controlled study of effects of oral progesterone on performance and mood. Br. J. Clin. Pharmacol. 1992, 33(3):293-298.
15. Frye C.A., Duncan J.E., Basham M., Erskine M.S. Behavioral effects of 3 alpha-androstanediol. II: Hypothalamic and preoptic area actions via a GABAergic mechanism. Behav. Brain Res. 1996, 79(1-2):119-130.
16. Frye C.A., Walf A.A., Rhodes M.E., Harney J.P. Progesterone enhances motor, anxiolytic, analgesic, and antidepressive behavior of wild-type mice, but not those deficient in type 1 5 alpha-reductase. Brain Res. 2004, 1004(1-2):116-124.
17. Gilbert Evans S.E., Ross L.E., Sellers E.M., Purdy R.H., Romach M.K. 3alpha-reduced neuroactive steroids and their precursors during pregnancy and the postpartum period. Gynecol. Endocrinol. 2005, 21(5):268-279.
18. Gillespie C.F., Nemeroff C.B. Hypercortisolemia and depression. Psychosom. Med. 2005, 67(Suppl. 1):S26-S28.
19. Girdler S.S., Straneva P.A., Light K.C., Pedersen C.A., Morrow A.L. Allopregnanolone levels and reactivity to mental stress in premenstrual dysphoric disorder. Biol. Psychiatry 2001, 49(9):788-797.
20. Guo A.L., Petraglia F., Criscuolo M., Ficarra G., Nappi R.E., Palumbo M.A., et al. Evidence for a role of neurosteroids in modulation of diurnal changes and acute stress-induced corticosterone secretion in rats. Gynecol. Endocrinol. 1995, 9(1):1-7.
21. Kavaliers M., Wiebe J.P. Analgesic effects of the progesterone metabolite, 3 alpha-hydroxy-5 alpha-pregnan-20-one, and possible modes of action in mice. Brain Res. 1987, 415(2):393-398.
22. Kirschbaum C., Pirke K.M., Hellhammer D.H. The 'Trier Social Stress Test'-a tool for investigating psychobiological stress responses in a laboratory setting. Neuropsychobiology 1993, 28(1-2):76-81.
23. Klatzkin R.R., Morrow A.L., Light K.C., Pedersen C.A., Girdler S.S. Associations of histories of depression and PMDD diagnosis with allopregnanolone concentrations following the oral administration of micronized progesterone. Psychoneuroendocrinology 2006, 31(10):1208-1219.
24. Klatzkin R.R., Morrow A.L., Light K.C., Pedersen C.A., Girdler S.S. Histories of depression, allopregnanolone responses to stress, and premenstrual symptoms in women. Biol. Psychol. 2006, 71(1):2-11.
25. Lewinsohn P.M., Zeiss A.M., Duncan E.M. Probability of relapse after recovery from an episode of depression. J. Abnorm. Psychol. 1989, 98(2):107-116.
26. Majewska M.D., Harrison N.L., Schwartz R.D., Barker J.L., Paul S.M. Steroid hormone metabolites are barbiturate-like modulators of the GABA receptor. Science 1986, 232(4753):1004-1007.
27. Maninger N., Capitanio J.P., Mason W.A., Ruys J.D., Mendoza S.P. Acute and chronic stress increase DHEAS concentrations in rhesus monkeys. Psychoneuroendocrinology 2010, 35(7):1055-1062.
28. McAuley J.W., Kroboth F.J., Kroboth P.D. Oral administration of micronized progesterone: a review and more experience. Pharmacotherapy 1996, 16(3):453-457.
29. McEwen B.S. Protective and damaging effects of stress mediators. N. Engl. J. Med. 1998, 338(3):171-179.
30. McKittrick C.R., Blanchard D.C., Blanchard R.J., McEwen B.S., Sakai R.R. Serotonin receptor binding in a colony model of chronic social stress. Biol. Psychiatry 1995, 37(6):383-393.
31. Miczek K.A., DeBold J.F., van Erp A.M., Tornatzky W. Alcohol, GABAA-benzodiazepine receptor complex, and aggression. Recent Dev. Alcohol. 1997, 13:139-171.
32. Miller G.E., Chen E., Zhou E.S. If it goes up, must it come down? Chronic stress and the hypothalamic-pituitary-adrenocortical axis in humans. Psychol. Bull. 2007, 133(1):25-45.
33. Monroe S.M., Harkness K.L. Life stress, the " Kindling" hypothesis, and the recurrence of depression: considerations from a life stress perspective. Psychol. Rev. 2005, 112(2):417-445.
34. Morrow A.L. Recent developments in the significance and therapeutic relevance of neuroactive steroids-introduction to the special issue. Pharmacol. Ther. 2007, 116(1):1-6.
35. Morrow A.L., Devaud L.L., Purdy R.H., Paul S.M. Neuroactive steroid modulators of the stress response. Ann. N. Y. Acad. Sci. 1995, 771:257-272.
36. Naert G., Maurice T., Tapia-Arancibia L., Givalois L. Neuroactive steroids modulate HPA axis activity and cerebral brain-derived neurotrophic factor (BDNF) protein levels in adult male rats. Psychoneuroendocrinology 2007, 32(8-10):1062-1078.
37. Nappi R.E., Petraglia F., Luisi S., Polatti F., Farina C., Genazzani A.R. Serum allopregnanolone in women with postpartum " blues" Obstet. Gynecol. 2001, 97(1):77-80.
38. Patchev V.K., Hassan A.H., Holsboer D.F., Almeida O.F. The neurosteroid tetrahydroprogesterone attenuates the endocrine response to stress and exerts glucocorticoid-like effects on vasopressin gene transcription in the rat hypothalamus. Neuropsychopharmacology 1996, 15(6):533-540.
39. Paul S.M., Purdy R.H. Neuroactive steroids. FASEB J. 1992, 6(6):2311-2322.
40. Porcu P., O'Buckley T.K., Alward S.E., Marx C.E., Shampine L.J., Girdler S.S., et al. Simultaneous quantification of GABAergic 3α,5α/3α,5β neuroactive steroids in human and rat serum. Steroids 2009, 74:463-473.
41. Prince M.J., Harwood R.H., Blizard R.A., Thomas A., Mann A.H. Social support deficits, loneliness and life events as risk factors for depression in old age. The Gospel Oak Project VI. Psychol. Med. 1997, 27(2):323-332.
42. Purdy R.H., Morrow A.L., Moore P.H., Paul S.M. Stress-induced elevations of gamma-aminobutyric acid type A receptor-active steroids in the rat brain. Proc. Natl. Acad. Sci. U. S. A. 1991, 88(10):4553-4557.
43. Reddy D.S. Physiological role of adrenal deoxycorticosterone-derived neuroactive steroids in stress-sensitive conditions. Neuroscience 2006, 138(3):911-920.
44. Roberts R.E., Kaplan G.A., Shema S.J., Strawbridge W.J. Does growing old increase the risk for depression?. Am. J. Psychiatry 1997, 154(10):1384-1390.
45. Romeo E., Strohle A., Spalletta G., di Michele F., Hermann B., Holsboer F., et al. Effects of antidepressant treatment on neuroactive steroids in major depression. Am. J. Psychiatry 1998, 155(7):910-913.
46. Sachar E.J., Hellman L., Fukushima D.K., Gallagher T.F. Cortisol production in depressive illness. A clinical and biochemical clarification. Arch. Gen. Psychiatry 1970, 23(4):289-298.
47. Serra M., Pisu M.G., Littera M., Papi G., Sanna E., Tuveri F., et al. Social isolation-induced decreases in both the abundance of neuroactive steroids and GABA (A) receptor function in rat brain. J. Neurochem. 2000, 75(2):732-740.
48. Siever L.J., Davis K.L. Overview: toward a dysregulation hypothesis of depression. Am. J. Psychiatry 1985, 142(9):1017-1031.
49. Simpson E.R., Waterman M.R. Regulation of the synthesis of steroidogenic enzymes in adrenal cortical cells by ACTH. Annu. Rev. Physiol. 1988, 50:427-440.
50. Steiger A., von Bardeleben U., Herth T., Holsboer F. Sleep EEG and nocturnal secretion of cortisol and growth hormone in male patients with endogenous depression before treatment and after recovery. J. Affect. Disord. 1989, 16(2-3):189-195.
51. Strohle A., Pasini A., Romeo E., Hermann B., Spalletta G., di Michele F., et al. Fluoxetine decreases concentrations of 3 alpha, 5 alpha-tetrahydrodeoxycorticosterone (THDOC) in major depression. J. Psychiatr. Res. 2000, 34(3):183-186.
52. Strohle A., Romeo E., Hermann B., Pasini A., Spalletta G., di Michele F., et al. Concentrations of 3 alpha-reduced neuroactive steroids and their precursors in plasma of patients with major depression and after clinical recovery. Biol. Psychiatry 1999, 45(3):274-277.
53. Strous R.D., Maayan R., Weizman A. The relevance of neurosteroids to clinical psychiatry: from the laboratory to the bedside. Eur. Neuropsychopharmacol. 2006, 16(3):155-169.
54. Uzunova V., Sampson L., Uzunov D.P. Relevance of endogenous 3alpha-reduced neurosteroids to depression and antidepressant action. Psychopharmacology (Berl) 2006, 186(3):351-361.
55. Uzunova V., Sheline Y., Davis J.M., Rasmusson A., Uzunov D.P., Costa E., et al. Increase in the cerebrospinal fluid content of neurosteroids in patients with unipolar major depression who are receiving fluoxetine or fluvoxamine. Proc. Natl. Acad. Sci. U. S. A. 1998, 95(6):3239-3244.
56. Vallee M., Rivera J.D., Koob G.F., Purdy R.H., Fitzgerald R.L. Quantification of neurosteroids in rat plasma and brain following swim stress and allopregnanolone administration using negative chemical ionization gas chromatography/mass spectrometry. Anal. Biochem. 2000, 287(1):153-166.
57. van Broekhoven F., Verkes R.J. Neurosteroids in depression: a review. Psychopharmacology (Berl) 2003, 165(2):97-110.
58. Zeger S.L., Liang K.Y., Albert P.S. Models for longitudinal data: a generalized estimating equation approach. Biometrics 1988, 44(4):1049-1060.